5 Cheap Pharmaceutical Stocks For 2022

4. Neoleukin Therapeutics, Inc. (NASDAQ:NLTX)

Number of Hedge Fund Holders: 16    

Real-Time Share Price as of February 15: $2.81

Neoleukin Therapeutics, Inc. (NASDAQ:NLTX) is a biopharma firm that develops therapies for cancer using protein design technology. One of the leading pipeline drugs for the firm is  NL-201, a protein that seeks to act as a therapeutic for the treatment of renal cell carcinoma and melanoma, among other cancers. 

Top hedge funds are exceedingly bullish on Neoleukin Therapeutics, Inc. (NASDAQ:NLTX). Among the hedge funds being tracked by Insider Monkey, California-based investment firm Redmile Group is a leading shareholder in Neoleukin Therapeutics, Inc. (NASDAQ:NLTX), with 3.5 million shares worth more than $25 million.